Human Capital News Roundup: Low birthweight infants, antibacterial soap, youth and tobacco advertising, and more.
Around the country, print, broadcast and online media outlets are covering the groundbreaking work of Robert Wood Johnson Foundation (RWJF) scholars, fellows and grantees. Some recent examples:
Surgeons do not include radiation oncologists early enough in the breast cancer treatment decision-making process, according to a study led by Robert Wood Johnson Foundation (RWJF) Physician Faculty Scholar Reshma Jagsi, MD, DPhil. The result is that patients are sometimes not informed about all their treatment options. Health Canal and Cardiovascular Business are among the outlets to report on the study.
Nurse.com reports that a study by Eileen Lake, PhD, RN, FAAN, and colleagues finds that some outcomes for very low-birth-weight infants are better at hospitals with Magnet recognition—those recognized for nursing excellence. Lake is a grantee of the RWJF Interdisciplinary Nursing Quality Research Initiative (INQRI). The study of more than 72,000 very low birthweight infants finds significantly lower rates of hospital infection, death at seven days and severe intraventricular hemorrhage among babies born at Magnet hospitals than those born at other hospitals. Read the study.
After student leaders at the University of Texas passed a resolution calling for administrators to ban antibacterial soap from campus on grounds of chemical and environmental concerns, RWJF Health & Society Scholars program alumnus Allison E. Aiello, PhD, MS, spoke to the Houston Chronicle. Aiello studies triclosan, an antibacterial chemical used in soaps and other products, at the Center for Society Epidemiology and Population Health at the University of Michigan School of Public Health.
Physician Faculty Scholar Michael Ong, MD, PhD, spoke to California Watch about the state’s Tobacco Education and Research Oversight Committee, which he chairs, and its efforts to minimize youth exposure to tobacco advertising.
RWJF Investigator Award in Health Policy Research recipient Michelle Mello, JD, PhD, MPhil, will be the principal evaluator of a new “disclosure, apology, and offer" plan in Massachusetts. It is designed to reduce the number of medical malpractice suits and the practice of "defensive medicine." Under the plan, patients who are harmed by medical errors at participating Massachusetts hospitals will be promptly informed of the error, given an apology and offered financial compensation. Patients would still have the right to sue, but the hospitals expect that straightforward disclosure will lead to less litigation. Boston.com’s Health Stew blog reports on the program.
Sigma Theta Tau International president and RWJF Executive Nurse Fellow Suzanne Prevost, PhD, RN, COI, was honored at a reception at the American Organization of Nurse Executives (AONE) conference in Boston, Reflections on Nursing Leadership reports. More than 80 nurse leaders were in attendance.
The Courier-Journal (Ky.) reports on the seventh annual Derby Divas fundraiser, which raised more than $95,000 for the Norton Healthcare Cancer Institute Breast Health Program. Executive Nurse Fellows alumna Lynnie Meyer, MSN, RN, is chief development officer at Norton Healthcare
David Wilkes, MD, gave comments to the Indianapolis Star about a research collaboration between the Indiana University School of Medicine—where Wilkes is executive associate dean for research affairs—and the Indiana University Health hospital system. The $150 million initiative will support research on cancer, heart disease and neurological diseases, such as autism and Alzheimer's. Wilkes is program director of the RWJF Harold Amos Medical Faculty Development Program.